Live Analyst Rating Changes 24315 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Charles Weston
RBC

Charles Weston

RBC Capital
Wall Street Analyst
★★★☆☆
#1682
on 13Foresight · ranked by our own returns
63%
Success Rate
-2.7%
Average Return
24 of 38 calls profitable · -8.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 63% of Charles Weston's ratings turned a profit when each position was held for 1 year — averaging -2.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

62 Buy 25 Hold 0 Sell
Charles's Stock Coverage 23 ratings · 2026-08-13
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
GB:OXB
Oxford BioMedica
 Aug 10, 2026 BUY Strong Buy
+74.7% avg upside
4 analysts
$900.00
83.20% Upside
 · ·
GB:SN
Smith & Nephew
 Aug 06, 2026 HOLD Buy
+1245.9% avg upside
16 analysts
$1250.00
12.51% Upside
 · ·
DE:AFX
Carl Zeiss Meditec
 Aug 06, 2026 HOLD Sell
+55.2% avg upside
13 analysts
$32.00
6.96% Upside
 · ·
CH:LONN
Lonza Group Ltd
 Aug 03, 2026 BUY Strong Buy
+13.9% avg upside
21 analysts
$760.00
32.26% Upside
 +1.8% ·
GB:CTEC
ConvaTec
 Aug 02, 2026 BUY Strong Buy
+27.1% avg upside
18 analysts
$315.00
34.15% Upside
 +0.6% ·
CH:BANB
Bachem Holding AG
 Jul 31, 2026 BUY Sell
-1.1% avg upside
4 analysts
$110.00
48.57% Upside
 -2.9% ·
DE:SRT3
Sartorius
 Jul 23, 2026 HOLD Buy
+15.7% avg upside
18 analysts
$220.00
6.79% Downside
 +3.9% ·
FR:DIM
Sartorius Stedim Biotech
 Jul 23, 2026 BUY Strong Buy
+38.2% avg upside
11 analysts
$210.00
16.76% Upside
 +4.2% ·
DE:EVT
Evotec
 Jul 14, 2026 BUY Buy
+346.9% avg upside
8 analysts
$10.00
168.34% Upside
 -1.2% ·
IT:1SXP
SCHOTT Pharma AG & Co. KGaA
 Jul 09, 2026 BUY Buy
-2.0% avg upside
6 analysts
$21.00
5.18% Downside
 +5.0% ·
CH:PPGN
PolyPeptide Group AG
 Jul 07, 2026 HOLD Strong Buy
-20.4% avg upside
3 analysts
$44.00
0.17% Upside
 -2.9% ·
GB:4BB
4basebio UK Societas
 Jun 15, 2026 BUY Strong Buy
+169.3% avg upside
1 analyst
$1400.00
169.29% Upside
 +0.0% ·
GB:ONT
Oxford Nanopore Technologies PLC
 May 26, 2026 BUY Strong Buy
+58.1% avg upside
6 analysts
$225.00
70.85% Upside
 -13.3% ·
CH:SFZN
Siegfried Holding AG
 Mar 16, 2026 HOLD Hold
+15.7% avg upside
3 analysts
$96.00
21.73% Upside
 +4.1% ·
GB:CVSG
CVS Group plc
 Mar 04, 2026 BUY Buy
+17.1% avg upside
4 analysts
$1900.00
46.29% Upside
 +0.2% ·
GB:UPR
Uniphar PLC
 Feb 24, 2026 BUY Strong Buy
+10.0% avg upside
3 analysts
$412.09
13.10% Upside
 -0.8% ·
LZAGY
Lonza Group
 Feb 11, 2026 BUY Strong Buy
+22.7% avg upside
2 analysts
 — +9.1% ·
SSB
SouthState Corporation
 Jan 07, 2025 BUY Strong Buy
+18.9% avg upside
16 analysts
$289.03
166.29% Upside
 +3.0% ·
GB:SPI
Spire Healthcare
 Nov 19, 2024 BUY Strong Buy
+27.5% avg upside
6 analysts
$310.00
33.24% Upside
 +0.5% ·
CH:MOLN
Molecular Partners AG
 Jul 12, 2021 BUY Strong Buy
+536.9% avg upside
5 analysts
$26.00
692.68% Upside
 -65.9% ·
SE:HNSA
Hansa Biopharma AB
 Apr 13, 2021 BUY Strong Buy
+241.2% avg upside
4 analysts
$287.00
596.85% Upside
 -60.4% ·
GB:IPO
IP Group plc
 Nov 02, 2018 BUY Strong Buy
+6503.9% avg upside
3 analysts
$160.00
127.56% Upside
 -49.8% ·
MDXH
MDxHealth
 Apr 24, 2018 BUY Strong Buy
+1251.3% avg upside
8 analysts
$7.05
1453.45% Upside
 · ·
🔒 18 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Charles Weston — Frequently Asked Questions
How accurate are Charles Weston's stock ratings?
Based on the calls 13Foresight could measure, about 63% of Charles's ratings were profitable over a one-year hold, with an average return of -2.7% per rating, or -8.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Charles ranked on 13Foresight?
Charles Weston is currently ranked #1682 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Charles cover?
Charles most recently has ratings on GB:OXB, GB:SN, DE:AFX, CH:LONN, GB:CTEC, CH:BANB, DE:SRT3, FR:DIM, DE:EVT, IT:1SXP, CH:PPGN, GB:4BB and 11 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.